40 related articles for article (PubMed ID: 6969149)
21. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
Carson DA; Kaye J; Matsumoto S; Seegmiller JE; Thompson L
Proc Natl Acad Sci U S A; 1979 May; 76(5):2430-3. PubMed ID: 313056
[TBL] [Abstract][Full Text] [Related]
22. Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.
Gelfand EW; Lee JJ; Dosch HM
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1998-2002. PubMed ID: 313053
[TBL] [Abstract][Full Text] [Related]
23. The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.
Uberti J; Lightbody JJ; Johnson RM
J Immunol; 1979 Jul; 123(1):189-93. PubMed ID: 312874
[TBL] [Abstract][Full Text] [Related]
24. Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen.
Moretta L; Mingari MC; Moretta A; Cooper MD
J Immunol; 1979 Mar; 122(3):984-90. PubMed ID: 312831
[No Abstract] [Full Text] [Related]
25. Differential sensitivity of human leukemic T cell lines and B cell lines to growth inhibition by deoxyadenosine.
Carson DA; Kaye J; Seegmiller JE
J Immunol; 1978 Nov; 121(5):1726-31. PubMed ID: 309480
[No Abstract] [Full Text] [Related]
26. Fc-receptor heterogeneity of human suppressor T cells.
Hayward AR; Layward L; Lydyard PM; Moretta L; Dagg M; Lawton AR
J Immunol; 1978 Jul; 121(1):1-5. PubMed ID: 307565
[TBL] [Abstract][Full Text] [Related]
27. Induction of plasma cell differentiation of human fetal lymphocytes: evidence for functional immaturity of T and B cells.
Hayward AR; Lawton AR
J Immunol; 1977 Oct; 119(4):1213-7. PubMed ID: 302276
[TBL] [Abstract][Full Text] [Related]
28. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
[TBL] [Abstract][Full Text] [Related]
29. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
Wortmann RL; Mitchell BS; Edwards NL; Fox IH
Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
[TBL] [Abstract][Full Text] [Related]
30. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
Carson DA; Kaye J; Seegmiller JE
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
[TBL] [Abstract][Full Text] [Related]
31. Role of adenosine deaminase in lymphocyte proliferation.
Hovi T; Smyth JF; Allison AC; Williams SC
Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
[TBL] [Abstract][Full Text] [Related]
32. Human B cell function in a polyclonally induced plaque forming cell system. Cell triggering and immunoregulation.
Fauci AS
Immunol Rev; 1979; 45():93-116. PubMed ID: 89732
[TBL] [Abstract][Full Text] [Related]
33. Regulation of B cell activity in man: role of T cells.
Ballieux RE; Heijnen CJ; Uytdehaag F; Zegers BJ
Immunol Rev; 1979; 45():3-39. PubMed ID: 89731
[No Abstract] [Full Text] [Related]
34. Regulation of human B cell activation.
Geha RS
Immunol Rev; 1979; 45():275-305. PubMed ID: 89730
[No Abstract] [Full Text] [Related]
35. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
36. A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Honma Y
Leuk Lymphoma; 2001; 42(5):953-62. PubMed ID: 11697650
[TBL] [Abstract][Full Text] [Related]
37. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
Hayward AR
Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
[TBL] [Abstract][Full Text] [Related]
38. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Niitsu N; Honma Y
Leuk Lymphoma; 1999 Jul; 34(3-4):261-71. PubMed ID: 10439363
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
